Peptide Comparison
Palmitoyl Dipeptide-6 vs Syn-Ake
Editorial breakdown of mechanism, evidence, decision criteria, and the misconceptions worth calling out.
Data-derived verdict
Palmitoyl Dipeptide-6 and Syn-Ake share the cosmetic class and carry roughly equivalent evidence (Cosmetic Clinical Studies / Cosmetic Clinical Studies). On the catalogued data layer Syn-Ake has a slight edge: more cited sources or efficacy data on file. For most research framings either pick is defensible; Syn-Ake's evidence base is currently denser.
Evidence at a glance
FDA-approved Phase 3 Phase 2 / approved abroad Anecdotal + animal Preclinical / flagged
Shared safety considerations
Both compounds share these reported concerns: minimal. Open each peptide page for the full risk paragraph and source citations.
Side-by-side
| Palmitoyl Dipeptide-6 | Syn-Ake | |
|---|---|---|
| Class | Cosmetic lipopeptide (retinol-mimic) | Cosmetic peptide (snake-venom inspired) |
| Drug class | Dermatologic | Dermatologic |
| Mechanism | Activates retinoid-responsive genes without retinoid irritation | Waglerin-1 mimic; antagonizes nicotinic ACh receptor at muscle |
| Route | Topical | Topical |
| Half-life | Topical | Topical |
| Dosage (research) | Topical 1-3% | Topical 4% |
| Evidence tier | Cosmetic Clinical Studies | Cosmetic Clinical Studies |
| Research depth | — | 5 indexed |
| Availability | Cosmetic | Cosmetic |
| Reported risks | Minimal | Minimal |
Reported research data only. "Studied for" and "reported in literature" describe published research focus, not clinical recommendation. Most peptides catalogued here are not FDA-approved for human use.
Frequently asked questions
Should I pick Palmitoyl Dipeptide-6 or Syn-Ake?
Palmitoyl Dipeptide-6 and Syn-Ake share the cosmetic class and carry roughly equivalent evidence (Cosmetic Clinical Studies / Cosmetic Clinical Studies). On the catalogued data layer Syn-Ake has a slight edge: more cited sources or efficacy data on file. For most research framings either pick is defensible; Syn-Ake's evidence base is currently denser.
What is the difference between Palmitoyl Dipeptide-6 and Syn-Ake?
Palmitoyl Dipeptide-6 is classed as Cosmetic lipopeptide (retinol-mimic); Syn-Ake is classed as Cosmetic peptide (snake-venom inspired). Reported mechanism: Palmitoyl Dipeptide-6, Activates retinoid-responsive genes without retinoid irritation; Syn-Ake, Waglerin-1 mimic; antagonizes nicotinic ACh receptor at muscle. Reported half-life: Palmitoyl Dipeptide-6, Topical; Syn-Ake, Topical. Routes in published studies: Palmitoyl Dipeptide-6, Topical; Syn-Ake, Topical.
Which has stronger evidence, Palmitoyl Dipeptide-6 or Syn-Ake?
Palmitoyl Dipeptide-6 and Syn-Ake sit on the same rung of PeptideHelper.org's five-step evidence scale, which runs from preclinical to FDA-approved. Palmitoyl Dipeptide-6 is graded Cosmetic Clinical Studies, with 2 cited sources on its reference page. Syn-Ake is graded Cosmetic Clinical Studies, with 3 cited sources on its reference page and 5 indexed studies.
Which is more accessible, Palmitoyl Dipeptide-6 or Syn-Ake?
Neither Palmitoyl Dipeptide-6 nor Syn-Ake is an FDA-approved drug. Catalog status: Palmitoyl Dipeptide-6, Cosmetic; Syn-Ake, Cosmetic.
Are Palmitoyl Dipeptide-6 and Syn-Ake ever combined?
Palmitoyl Dipeptide-6 and Syn-Ake appear together in no stack catalogued on PeptideHelper.org, and the interaction engine raises no flag for the pair.
Open the PeptideHelper.org compare tool to add more compounds to this side-by-side and filter by evidence tier interactively.
Loading interactive view…